Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer

Clinical trial NCT01238029 · TERMINATED

Trial details

NCT number: NCT01238029
Sponsor: Sponsor GmbH
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer HER2 Positive First or Second Line Therapy Failure or Contraindication of Trastuzumab Therapy

Start date: 2010-10-01
Primary completion: 2014-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.